Key facts
- This page summarizes Tycho Peterson's Form 4 filing for Adaptive Biotechnologies Corp (ADPT).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Jun 2023, 17:32.
Tycho Peterson - 20 Jun 2023 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ADPT
- Reported as of
- 20 Jun 2023
- Net transaction value
- -$113,367
- SEC form
- 4
- Accepted by SEC
- 21 Jun 2023, 17:32:56 UTC
- Prior SEC filing
- 20 Jun 2023
- Next SEC filing
- 09 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tycho Peterson by Stacy L Taylor, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Tycho Peterson filed Form 4 for Adaptive Biotechnologies Corp (ADPT) on 21 Jun 2023.
Change
- Previous filing in this sequence was filed on 20 Jun 2023.
- Current net transaction value: -$113,367.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADPT
transaction
Common Stock
Options Exercise
- Transaction value
- $985,215
- Shares
- +134,961
- Change %
- +34%
- Price
- $7.30
- Shares after
- 534,180
- Date
- 20 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
ADPT
transaction
Common Stock
Sale
- Transaction value
- $569,800
- Shares
- -70,000
- Change %
- -13%
- Price
- $8.14
- Shares after
- 464,180
- Date
- 20 Jun 2023
- Ownership
- Direct
- Footnotes
- F1, F2
ADPT
transaction
Common Stock
Sale
- Transaction value
- $528,783
- Shares
- -64,961
- Change %
- -14%
- Price
- $8.14
- Shares after
- 399,219
- Date
- 20 Jun 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ADPT
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -134,961
- Change %
- -23%
- Price
- $0.000000
- Shares after
- 447,868
- Date
- 20 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 134,961
- Exercise price
- $7.30
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2023.
Footnote F2
The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.00 to $8.34, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
Footnote F3
The options vested with respect to 1/4 of such shares on June 1, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.